SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-011535
Filing Date
2024-03-27
Accepted
2024-03-27 17:00:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 29684
  Complete submission text file 0001493152-24-011535.txt   30789
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41184 | Film No.: 24791656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)